{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:51:34Z","timestamp":1791669094101,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05237-w","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:55:28Z","timestamp":1786359328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of nephrectomy on liver and contralateral kidney volume in patients with ADPKD; a case series"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-9727","authenticated-orcid":false,"given":"Paul","family":"Geertsema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H. J.","family":"Doornweerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maatje D. A.","family":"van Gastel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek F.","family":"Casteleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"2","key":"5237_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000525575","volume":"107","author":"NF Casteleijn","year":"2023","unstructured":"Casteleijn NF, Geertsema P, Koorevaar IW, Inkelaar FDJ, Jansen MR, Lohuis SJ, et al. The need for routine native nephrectomy in the workup for kidney transplantation in autosomal dominant polycystic kidney disease patients. Urol Int. 2023;107(2):148\u201356. https:\/\/doi.org\/10.1159\/000525575.","journal-title":"Urol Int"},{"key":"5237_CR2","doi-asserted-by":"publisher","unstructured":"Chebib FT, Prieto M, Yeonsoon J, Irazabal MV, Kremers WK, Dean PG, et al. Native nephrectomy in renal transplant recipients with autosomal-dominant polycystic kidney disease. Transpl Direct. 2015;1(10):e43. https:\/\/doi.org\/10.1097\/TXD.0000000000000554.","DOI":"10.1097\/TXD.0000000000000554"},{"issue":"5","key":"5237_CR3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/ndt\/gfaf019","volume":"40","author":"P Geertsema","year":"2025","unstructured":"Geertsema P, Gansevoort RT, Arici M, Capasso G, Cornec-Le Gall E, Furlano M, et al. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA genes & kidney working group. Nephrol Dial Transpl. 2025;40(5):1032\u201354. https:\/\/doi.org\/10.1093\/ndt\/gfaf019.","journal-title":"Nephrol Dial Transpl"},{"key":"5237_CR4","doi-asserted-by":"publisher","unstructured":"Veroux M, Zerbo D, Basile G, Gozzo C, Sinagra N, Giaquinta A, et al. Simultaneous native nephrectomy and kidney transplantation in patients with autosomal dominant polycystic kidney disease. PLoS One. 2016;11(6):e0155481. https:\/\/doi.org\/10.1371\/journal.pone.0155481.","DOI":"10.1371\/journal.pone.0155481"},{"issue":"4","key":"5237_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4111\/icu.2018.59.4.238","volume":"59","author":"K Chen","year":"2018","unstructured":"Chen K, Tan YG, Tan D, Pek G, Huang HH, Sim SPA. Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. Investig Clin Urol. 2018;59(4):238\u201345. https:\/\/doi.org\/10.4111\/icu.2018.59.4.238.","journal-title":"Investig Clin Urol"},{"key":"5237_CR6","doi-asserted-by":"publisher","unstructured":"Devuyst O, Ahn C, Barten TRM, Brosnahan G, Cadnapaphornchai MA, Chapman AB, et al. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD). Kidney Int. 2025;107(2):S1\u2013239. https:\/\/doi.org\/10.1016\/j.kint.2024.07.009.","DOI":"10.1016\/j.kint.2024.07.009"},{"issue":"1","key":"5237_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mayocpiqo.2022.12.005","volume":"7","author":"T Suwabe","year":"2023","unstructured":"Suwabe T, Ubara Y, Oba Y, Mizuno H, Ikuma D, Yamanouchi M, et al. Changes in kidney and liver volumes in patients with autosomal dominant polycystic kidney disease before and after dialysis initiation. Mayo Clinic Proc: Innovations, Qual Outcomes. 2023;7(1):69\u201380. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.12.005.","journal-title":"Mayo Clinic Proc: Innovations, Qual Outcomes"},{"issue":"1","key":"5237_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ndt\/gfv227","volume":"31","author":"Y Jung","year":"2016","unstructured":"Jung Y, Irazabal MV, Chebib FT, Harris PC, Dean PG, Prieto M, et al. Volume regression of native polycystic kidneys after renal transplantation. Nephrol Dial Transpl. 2016;31(1):73\u201379. https:\/\/doi.org\/10.1093\/ndt\/gfv227.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"5237_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/TP.0b013e318246f910","volume":"93","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Watarai Y, Kobayashi T, Matsuda Y, Tsujita M, Hiramitsu T, et al. Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation. 2012;93(8):794\u201398. https:\/\/doi.org\/10.1097\/TP.0b013e318246f910.","journal-title":"Transplantation"},{"issue":"5","key":"5237_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5414\/CN111036","volume":"99","author":"JE Gaytan-Arocha","year":"2023","unstructured":"Gaytan-Arocha JE, Perez-Segovia A, Reul-Linares E, Hern\u00e1ndez-Paredes EN, Chapa-Ibarg\u00fcengoitia M, Correa-Rotter R, et al. Effect of kidney transplantation on cyst growth in autosomal dominant polycystic kidney disease. CN. 2023;99(5):228\u201336. https:\/\/doi.org\/10.5414\/CN111036.","journal-title":"CN"},{"issue":"4","key":"5237_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","volume":"68","author":"RMM van Aerts","year":"2018","unstructured":"van Aerts RMM, van de Laarschot LFM, Banales JM, Drenth JPH. Clinical management of polycystic liver disease. J Hepatol. 2018;68(4):827\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.024.","journal-title":"J Hepatol"},{"issue":"8","key":"5237_CR12","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1681\/ASN.2018090902","volume":"30","author":"MDA van Gastel","year":"2019","unstructured":"van Gastel MDA, Edwards ME, Torres VE, Erickson BJ, Gansevoort RT, Kline TL. Automatic measurement of kidney and liver volumes from MR images of patients affected by autosomal dominant polycystic kidney disease. JASN. 2019;30(8):1514\u201322. https:\/\/doi.org\/10.1681\/ASN.2018090902.","journal-title":"JASN"},{"issue":"12","key":"5237_CR13","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.34067\/KID.0003192022","volume":"3","author":"P Woznicki","year":"2022","unstructured":"Woznicki P, Siedek F, van Gastel MDA, dos Santos DP, Arjune S, Karner LA, et al. Automated kidney and liver segmentation in MR images in patients with autosomal dominant polycystic kidney disease: a multicenter study. Kidney360. 2022;3(12):2048\u201358. https:\/\/doi.org\/10.34067\/KID.0003192022.","journal-title":"Kidney360"},{"issue":"3","key":"5237_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int. 2003;64(3):1035\u201345. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00185.x.","journal-title":"Kidney Int"},{"issue":"2","key":"5237_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"key":"5237_CR16","doi-asserted-by":"publisher","unstructured":"Veroux M, Gozzo C, Corona D, Murabito P, Caltabiano DC, Mammino L, et al. Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease. PLoS One. 2018;13(12):e0209332. https:\/\/doi.org\/10.1371\/journal.pone.0209332.","DOI":"10.1371\/journal.pone.0209332"},{"issue":"5","key":"5237_CR17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1046\/j.1523-1755.1999.00747.x","volume":"56","author":"CA Binkert","year":"1999","unstructured":"Binkert CA, Hoffman U, Leung DA, Matter H-G, Schmidt M, Debatin JF. Characterization of renal artery stenoses based on magnetic resonance renal flow and volume measurements. Kidney Int. 1999;56(5):1846\u201354. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00747.x.","journal-title":"Kidney Int"},{"key":"5237_CR18","doi-asserted-by":"publisher","unstructured":"Shillingford JM, Murcia NS, Larson CH, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proceedings of the National Academy of Sciences. 2006;5466\u201371. https:\/\/doi.org\/10.1073\/pnas.0509694103.","DOI":"10.1073\/pnas.0509694103"},{"issue":"3","key":"5237_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1681\/asn.2007050626","volume":"19","author":"Q Qian","year":"2008","unstructured":"Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol. 2008;19(3):631\u201338. https:\/\/doi.org\/10.1681\/asn.2007050626.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5237_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.transproceed.2018.02.060","volume":"50","author":"S Davis","year":"2018","unstructured":"Davis S, Gralla J, Chan L, Wiseman A, Edelstein CL. Effect of Sirolimus on native total kidney volume after transplantation in patients with autosomal dominant polycystic kidney disease: a randomized controlled pilot study. Transpl Proc. 2018;50(5):1243\u201348. https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.060.","journal-title":"Transpl Proc"},{"issue":"2","key":"5237_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.0000000000000034","volume":"18","author":"D Oberdhan","year":"2023","unstructured":"Oberdhan D, Cole JC, Atkinson MJ, Krasa HB, Davison SN, Perrone RD. Development of a patient-reported outcomes tool to assess pain and discomfort in autosomal dominant polycystic kidney disease. CJASN. 2023;18(2):213\u201322. https:\/\/doi.org\/10.2215\/CJN.0000000000000034.","journal-title":"CJASN"},{"issue":"1","key":"5237_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hep.28545","volume":"64","author":"MK Neijenhuis","year":"2016","unstructured":"Neijenhuis MK, Gevers TJG, Hogan MC, Kamath PS, Wijnands TFM, van den Ouweland RCPM, et al. Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease. Hepatology. 2016;64(1):151\u201360. https:\/\/doi.org\/10.1002\/hep.28545.","journal-title":"Hepatology"},{"issue":"9","key":"5237_CR23","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/liv.14986","volume":"41","author":"SE Aapkes","year":"2021","unstructured":"Aapkes SE, Bernts LHP, Barten TRM, van den Berg M, Gansevoort RT, Drenth JPH. Estrogens in polycystic liver disease: a target for future therapies? Liver Int. 2021;41(9):2009\u201319. https:\/\/doi.org\/10.1111\/liv.14986.","journal-title":"Liver Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05237-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05237-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05237-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:42:22Z","timestamp":1791668542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05237-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5237"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05237-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients. The use of these patient data was approved by the Institutional Review Board of the University Medical Center Groningen (METc 2013\/040 and RR 202200061).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"602"}}